Literature DB >> 16311290

HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometrium.

B F Barrier1, B S Kendall, C E Ryan, K L Sharpe-Timms.   

Abstract

BACKGROUND: HLA-G is a major histocompatability antigen with documented immune-regulatory function. Various epithelial cancers and tissue allografts have been noted to express HLA-G, which is postulated to aid in their escape from immunosurveillance. We evaluated peritoneal endometriosis and eutopic endometrium for the expression of HLA-G protein and gene transcript.
METHODS: Two experiments were performed: (i) archived tissue blocks from peritoneal endometriotic lesions (n = 15) and eutopic endometrium (n = 12) were evaluated for extent of protein immunostaining, and (ii) eutopic endometrial biopsies from women without (n = 17) and with (n = 24) endometriosis, and peritoneal endometriotic lesions (n = 14) were evaluated for presence of RNA transcript by in situ hybridization.
RESULTS: HLA-G protein localized in the glandular epithelium of 14 of 15 (93.3%) peritoneal endometriotic lesions, but not in stromal cells. HLA-G protein staining was absent in endometrial biopsies (n = 12). HLA-G gene transcript localized to the glandular epithelium in 13 of 14 (92.8%) peritoneal endometriotic lesions. HLA-G transcript was never observed in eutopic endometrium, regardless of cycle stage or whether from women with (n = 24) or without (n = 18) endometriosis.
CONCLUSIONS: HLA-G is expressed by endometriotic glandular epithelium but not by eutopic endometrium under normal conditions. Differential expression of HLA-G suggests that peritoneal inflammation or cellular stress may up-regulate mechanisms to promote ectopic endometrial survival.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311290     DOI: 10.1093/humrep/dei408

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

Review 1.  Endometrial biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Devashana Gupta; M Louise Hull; Ian Fraser; Laura Miller; Patrick M M Bossuyt; Neil Johnson; Vicki Nisenblat
Journal:  Cochrane Database Syst Rev       Date:  2016-04-20

Review 2.  Molecular aspects of development and regulation of endometriosis.

Authors:  Yana B Aznaurova; Marat B Zhumataev; Tiffany K Roberts; Alexander M Aliper; Alex A Zhavoronkov
Journal:  Reprod Biol Endocrinol       Date:  2014-06-13       Impact factor: 5.211

3.  Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies.

Authors:  Olimpia Sipak-Szmigiel; Piotr Włodarski; Elżbieta Ronin-Walknowska; Andrzej Niedzielski; Beata Karakiewicz; Sylwia Słuczanowska-Głąbowska; Maria Laszczyńska; Witold Malinowski
Journal:  J Ovarian Res       Date:  2017-04-04       Impact factor: 4.234

4.  The impact of HLA-G, LILRB1 and LILRB2 gene polymorphisms on susceptibility to and severity of endometriosis.

Authors:  Aleksandra Bylińska; Karolina Wilczyńska; Jacek Malejczyk; Łukasz Milewski; Marta Wagner; Monika Jasek; Wanda Niepiekło-Miniewska; Andrzej Wiśniewski; Rafał Płoski; Ewa Barcz; Piotr Roszkowski; Paweł Kamiński; Andrzej Malinowski; Jacek R Wilczyński; Paweł Radwan; Michał Radwan; Piotr Kuśnierczyk; Izabela Nowak
Journal:  Mol Genet Genomics       Date:  2017-12-12       Impact factor: 3.291

Review 5.  NK Cells as Potential Targets for Immunotherapy in Endometriosis.

Authors:  Aneta Ścieżyńska; Michał Komorowski; Marta Soszyńska; Jacek Malejczyk
Journal:  J Clin Med       Date:  2019-09-14       Impact factor: 4.241

Review 6.  HLA-G Neo-Expression on Tumors.

Authors:  Maria Loustau; François Anna; Raphaelle Dréan; Martin Lecomte; Pierre Langlade-Demoyen; Julien Caumartin
Journal:  Front Immunol       Date:  2020-08-14       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.